Nanexa receives Notice of Allowance for its US patent application
Uppsala 15thNovember 2018
Nanexa receives Notice of Allowance for its US patent application
The US patent office has issued a “Notice of Allowance” in Nanexa´s US patent application regarding the Company’s drug delivery platform PharmaShell®.
Positive results in the feasibility study lead to broader cooperation
Pressrelease
Uppsala 10th October 2018
Positive results in the feasibility study lead to broader cooperation
AstraZeneca has conducted a feasibility study for investigating specific properties of Nanexa’s drug delivery platform PharmaShell®.
